FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 36.070
AS - Asia 19.673
EU - Europa 14.928
SA - Sud America 2.799
Continente sconosciuto - Info sul continente non disponibili 1.404
AF - Africa 460
OC - Oceania 73
Totale 75.407
Nazione #
US - Stati Uniti d'America 34.248
SG - Singapore 6.492
IT - Italia 5.011
CN - Cina 3.910
VN - Vietnam 2.930
HK - Hong Kong 2.515
RU - Federazione Russa 2.027
BR - Brasile 1.993
DE - Germania 1.346
CA - Canada 1.332
IE - Irlanda 1.182
SE - Svezia 1.062
BD - Bangladesh 1.004
GB - Regno Unito 856
FR - Francia 780
UA - Ucraina 711
IN - India 542
FI - Finlandia 387
ID - Indonesia 382
KR - Corea 311
TR - Turchia 305
ES - Italia 293
NL - Olanda 265
AR - Argentina 255
JP - Giappone 219
AT - Austria 210
MX - Messico 209
IQ - Iraq 194
CO - Colombia 158
ZA - Sudafrica 139
PL - Polonia 124
SA - Arabia Saudita 118
PH - Filippine 113
EC - Ecuador 107
PK - Pakistan 105
DK - Danimarca 104
CH - Svizzera 86
VE - Venezuela 81
BE - Belgio 73
CL - Cile 73
CZ - Repubblica Ceca 66
JM - Giamaica 64
MA - Marocco 63
AU - Australia 62
EG - Egitto 59
TH - Thailandia 53
MY - Malesia 52
UZ - Uzbekistan 52
CR - Costa Rica 51
AE - Emirati Arabi Uniti 50
GR - Grecia 50
PE - Perù 50
RO - Romania 43
KE - Kenya 42
PT - Portogallo 40
PY - Paraguay 39
TN - Tunisia 36
IR - Iran 33
LT - Lituania 32
HN - Honduras 31
SK - Slovacchia (Repubblica Slovacca) 31
IL - Israele 27
JO - Giordania 27
NP - Nepal 27
UY - Uruguay 27
KZ - Kazakistan 24
ET - Etiopia 23
SV - El Salvador 23
BG - Bulgaria 22
EE - Estonia 22
DZ - Algeria 21
TT - Trinidad e Tobago 21
PS - Palestinian Territory 20
TW - Taiwan 20
GT - Guatemala 19
LB - Libano 19
RS - Serbia 19
NI - Nicaragua 18
AL - Albania 17
AZ - Azerbaigian 17
OM - Oman 17
EU - Europa 15
LV - Lettonia 15
SN - Senegal 15
HU - Ungheria 11
CI - Costa d'Avorio 10
KH - Cambogia 10
KW - Kuwait 10
LK - Sri Lanka 10
MD - Moldavia 10
BO - Bolivia 9
NG - Nigeria 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
BB - Barbados 8
DO - Repubblica Dominicana 8
GE - Georgia 8
KG - Kirghizistan 8
AO - Angola 7
BH - Bahrain 7
Totale 73.867
Città #
Ashburn 3.931
Singapore 3.683
Ann Arbor 3.294
Hong Kong 2.449
San Jose 1.996
Woodbridge 1.572
Fairfield 1.494
Milan 1.317
Houston 1.144
Dublin 1.119
Council Bluffs 1.089
Chandler 950
Ho Chi Minh City 887
New York 853
Toronto 835
Wilmington 832
Santa Clara 773
Hanoi 717
Jacksonville 707
Frankfurt am Main 679
Seattle 676
Los Angeles 666
Dallas 607
Hefei 604
Chicago 560
Cambridge 521
Dearborn 492
Rome 453
The Dalles 441
Beijing 434
Princeton 429
Boardman 297
Seoul 282
Lauterbourg 272
Jakarta 267
Buffalo 241
Hangzhou 227
Moscow 219
Nanjing 212
Shanghai 201
Lawrence 194
Columbus 191
São Paulo 183
Phoenix 181
Altamura 170
Helsinki 164
Vienna 145
Tokyo 134
Atlanta 132
San Diego 126
London 122
Brooklyn 119
Nuremberg 117
Figino 112
Lachine 112
Da Nang 108
Guangzhou 106
Denver 103
Montreal 103
Orem 102
Haiphong 91
Munich 90
Naples 90
Lissone 88
Washington 86
Nanchang 81
Turin 80
Baghdad 77
Chennai 74
San Francisco 74
Warsaw 74
Istanbul 73
Boston 70
Elk Grove Village 69
Salt Lake City 69
Johannesburg 68
Ottawa 68
Philadelphia 67
Amsterdam 64
Rio de Janeiro 64
Andover 62
Bologna 62
Lappeenranta 61
Shenyang 57
Dong Ket 56
Florence 55
Manchester 55
Fremont 53
Changsha 52
Baltimore 51
Brno 50
Kent 50
Queens 49
Tampa 49
Brasília 48
Mexico City 48
Biên Hòa 47
Charlotte 47
Dhaka 46
Ankara 45
Totale 43.706
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 1.121
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 1.056
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 656
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 572
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 566
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 514
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 500
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 487
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 484
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 480
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 467
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 432
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 424
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 422
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 417
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 406
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 406
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 398
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 395
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 393
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 381
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 378
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 369
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 368
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 362
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 361
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 361
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 359
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers 355
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 355
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 354
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 349
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 348
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 347
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 347
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 343
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 342
Analysis of gene expression in early-stage ovarian cancer 340
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 340
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 337
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 335
Delaying surgery for patients with a previous SARS-CoV-2 infection 334
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 330
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 324
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 323
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 321
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 321
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 320
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 318
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 317
Low-Volume Metastases in Cervical Cancer: Does Size Matter? 312
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 306
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 306
Association between physical activity and menstrual cycle disorders in young athletes 305
Fertility outcomes in stage I ovarian immature teratomas 303
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 301
Synchronous early-stage endometrial and ovarian cancer 299
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 299
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 298
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause 297
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 297
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 294
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 293
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 293
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 292
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 292
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 291
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 290
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 288
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 284
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 284
An exploration of body image distress in women who underwent a prophylactic bilateral salpingo-oophorectomy (PBSO) 284
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 282
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 281
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 281
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 280
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 273
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 272
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 272
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 272
Borderline ovarian cancer 272
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 271
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 270
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 270
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 270
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 270
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 268
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 267
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 267
PRL-3 phosphatase is implicated in ovarian cancer growth 262
Systematic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgery and chemotherapy: a retrospective study 260
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 259
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 257
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy 256
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 256
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 254
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 254
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 254
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management 253
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 253
Totale 34.899
Categoria #
all - tutte 244.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.987 0 0 0 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202628.226 3.093 2.037 1.923 2.581 2.816 1.364 3.485 1.323 2.085 2.479 2.218 2.822
2026/20279.848 1.493 1.738 3.290 3.327 0 0 0 0 0 0 0 0
Totale 75.407